F-group (family)
2007.1.14.3 Ferrochelatase
Ligands and drugs
945
Member domains
168
with ligand contacts (≤ 4 Å)
17.8% of members
150
with DrugDomain annotations
15.9% of members
105
with a DrugBank compound
11.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.1.14.3 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02659 | CHD | Cholic Acid | 60 |
| DB18267 | HEM | Ferroheme | 26 |
| DB02285 | PP9 | Protoporphyrin | 22 |
| DB09140 | OXY | Oxygen | 3 |
| DB00936 | SAL | Salicylic acid | 2 |
| DB01911 | MMP | N-Methylmesoporphyrin | 2 |
| DB02188 | MP1 | N-Methylmesoporphyrin containing copper | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FES | FE2/S2 (INORGANIC) CLUSTER | 108 |
| CHD | CHOLIC ACID | 88 |
| CL | CHLORIDE ION | 40 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 26 |
| PP9 | PROTOPORPHYRIN IX | 22 |
| MGmetal | MAGNESIUM ION | 19 |
| 9UM | 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione | 14 |
| HT9 | coproporphyrin III | 12 |
| FE2metal | FE (II) ION | 9 |
| FDE | FE(III) DEUTEROPORPHYRIN IX | 8 |
| COmetal | COBALT (II) ION | 6 |
| FEmetal | FE (III) ION | 4 |
| FEC | 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX | 4 |
| GF9 | 2-[[(4-chlorophenyl)amino]methyl]-5-propyl-6H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one | 4 |
| GFO | 2-(4-tert-butylphenyl)-5-[(quinolin-2-ylamino)methyl]-6H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one | 4 |
| H01 | PROTOPORPHYRIN IX 2,4-DISULFONIC ACID | 4 |
| ZNmetal | ZINC ION | 4 |
| OXY | OXYGEN MOLECULE | 3 |
| CAmetal | CALCIUM ION | 2 |
| CDmetal | CADMIUM ION | 2 |